Anebulo Pharmaceuticals (ANEB) PT Lowered to $8 at Benchmark
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Price: $2.33 +8.37%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 24 | New: 55
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 24 | New: 55
Join SI Premium – FREE
Benchmark analyst Robert Wasserman lowered the price target on Anebulo Pharmaceuticals (NASDAQ: ANEB) to $8.00 (from $10.00) while maintaining a Speculative Buy rating.
You May Also Be Interested In
- JinkoSolar Holding Co., Ltd. (JKS) PT Lowered to $11.74 at GLJ Research, 'among the best when looking for solar “parts players” to short'
- Adastria Co Ltd (2685:JP) PT Raised to JPY4,600 at JPMorgan
- Craig-Hallum Downgrades Planet Labs (PL) to Hold, 'Revenue Pause Likely To Last Longer Than Expected'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
